Evidence map›Paper›PMID 40877180›Full record

ArticleIn vivo (Athens, Greece)

Cantharidin Suppresses Cell Viability and Induces Apoptosis of SK-N-SH and SH-SY5Y Cells.

Jen-Sheng Pei, Hsu-Tung Lee, Chao-Chun Chen, Pei-Chen Hsu, Jaw-Chyun Chen, Te-Chun Hsia, Wen-Shin Chang, DA-Tian Bau, Chia-Wen Tsai

Abstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jen-Sheng Pei *Department of Pediatrics, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan, R.O.C.
Hsu-Tung Lee *Division of Neurosurgical Oncology, Department of Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
Chao-Chun Chen *Department of Pediatrics, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan, R.O.C.
Pei-Chen HsuDepartment of Pediatrics, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan, R.O.C.
Jaw-Chyun ChenDepartment of Medicinal Botanicals and Foods on Health Applications, Da-Yeh University, Changhua, Taiwan, R.O.C.
Te-Chun HsiaDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, R.O.C.
Wen-Shin ChangTerry Fox Cancer Research Laboratory, China Medical University Hospital, Taichung, Taiwan, R.O.C.
DA-Tian BauTerry Fox Cancer Research Laboratory, China Medical University Hospital, Taichung, Taiwan, R.O.C.; 013280@tool.caaumed.org.tw.
Chia-Wen TsaiTerry Fox Cancer Research Laboratory, China Medical University Hospital, Taichung, Taiwan, R.O.C.; 017891@tool.caaumed.org.tw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimNeuroblastoma (NBL) is a pediatric malignancy with high mortality, particularly within the first year of life. Cantharidin, a natural terpenoid derived from blister beetles, has shown anticancer activity against several malignancies; however, its effect on NBL remains unexplored. In this study, we evaluated the antiproliferative and pro-apoptotic effects of cantharidin on SH-SY5Y and SK-N-SH NBL cell lines. MATERIALS AND

methodsThe cell viability and appearance of sub-G

resultsMTT assays revealed that treatment with 5 and 10 μM cantharidin for 24 and 48 h significantly reduced viability of both SH-SY5Y and SK-N-SH cells (all

conclusionThese findings support the hypothesis that cantharidin induces apoptosis

Indexed as

Antineoplastic AgentsApoptosisCantharidinNeuroblastomaApoptosis Regulatory ProteinsCell Line, TumorCell ProliferationCell SurvivalHumansSignal TransductionAntineoplastic AgentsApoptosis Regulatory ProteinsCantharidinApoptosiscantharidinneuroblastomaproliferationviability

Identifiers

PMID40877180
PMCPMC12396070

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.